Image
coming
soon
Bal Johal
VP Device Development and NIOX Technical Operations
Circassia

Bal has 20+ years’ experience developing multiple drug device combination products, having worked at Glaxo developing respiratory drug-device combination products, including Advair, Flovent and Serevent Diskus, and numerous aerosol metered dose inhalers, for global registration, as well as supporting the development of Relenza/ Zanamivir, a multi dose dry powder inhaler for the treatment of influenza, and Ayamyst Nasal Spray. During her time at Pfizer, Bal supported the inhaled and injector drug product portfolios, including Exubera (inhaled insulin) and branded generic dry powder inhaler, and established in-vivo/ in-vitro correlation models for inhaled products, developing Breathing Simulators, Oropharyngeal Casts and Inhalation monitoring. During her tenure at Mundipharma, she led the CMC and device activities with partner Skyepharma for flutiform aerosol metered dose inhaler and breath actuated inhaler, working closely with the global independent associates as a key note speaker to support the product launch across Europe, Middle East and South East Asia. 

My Sessions
Bringing to Market: NIOX VERO® Plus
-
Presentation HealthTech Stage D80

 


4,000
ATTENDEES
200
EXHIBITORS
3
CONFERENCE STAGES
34
COUNTRIES REPRESENTED

Thanks to our supporters